DL-Dapoxteine HCL; N,N-DiMethyl-1-phenyl-3-(1-naphthalenyloxy)propanaMinehydrochloride; (S)-N,N-Dimethyl-3-(naphthalen-1-yloxy)-1-phenylpropan-1-amine hydrochloride; LY-210448 hydrochloride
CAS:129938-20-1
Chemical Formula:C21H24ClNO
Molecular Weight:341.88
Availability: R&D; Commercialization
⬤ CAS No.129938-20-1
⬤ Packaging type：
20kg barrel；5kg barrel；1kg bag；500g bag ; Customized Packaging
| Product Name | LY 210448 hydrochloride |
| CAS No. | 129938-20-1 |
| Chemical Formula | C21H24ClNO |
| Molecular Weight | 341.88 |
| Related Categories | API for the treatment of premature ejaculation |
| EINECS | 640-411-8 |
| Storage conditions | room temp |
| Solubility | Dimethyl sulfoxide: ≥20 mg/mL |
| Form | powder |
| Color | White |
| Melting point | 175-179℃ |
| Specific rotation | D +135.78° (c = 2.18 in methanol) |
| Optical activity | [α]/D +125 to +135°, c = 1 in methanol |
| Merck | 14,2821 |
| InChIKey | IHWDIQRWYNMKFM-OZYVVJTJNA-N |
| InChI | InChI=1/C21H23NO.ClH/c1-22(2)20(18-10-4-3-5-11-18)15-16-23-21-14-8-12-17-9-6-7-13-19(17)21;/h3-14,20H,15-16H2,1-2H3;1H/t20-;/s3 |
| SMILES | O(C1=CC=CC2C=CC=CC1=2)CC[C@@H](C1C=CC=CC=1)N(C)C.Cl |&1:13,r| |
| Biological Activity | LY-210448 is a short-acting, novel selective serotonin reuptake inhibitor. |
| Application | It is organic synthesis intermediates and pharmaceutical intermediates & API, which can be used in laboratory research and development processes and chemical pharmaceutical synthesis processes. |
Exceptional Product Quality
“We have been sourcing pharmaceuticals from Tianming Pharmaceutical for several years now, and their product quality has consistently exceeded our expectations. Each batch undergoes rigorous testing, ensuring we receive only the highest quality products. This reliability has significantly contributed to our trust and satisfaction with their services. Highly recommended!”
June 15, 2023
Outstanding Technical Guidance
“The technical guidance provided by Tianming Pharmaceutical’s team has been invaluable to our research and development projects. Their experts are knowledgeable, responsive, and always willing to assist with detailed explanations and support. Their guidance has enabled us to optimize our processes and achieve remarkable results. We couldn’t ask for a better partner.”
June 15, 2023
Superior Service Experience
“Our experience with Tianming Pharmaceutical has been nothing short of excellent. Their customer service team is exceptionally responsive and dedicated to meeting our needs. From initial consultation to after-sales support, they have provided seamless, professional service. Their commitment to customer satisfaction is truly commendable.”
June 15, 2023
Precise Product Specifications
“Tianming Pharmaceutical has impressed us with their adherence to precise product specifications. Each order is meticulously packaged and delivered exactly as requested, ensuring that we receive products that perfectly meet our requirements. Their attention to detail and commitment to accuracy have made them a trusted supplier for our business.”
June 15, 2023
Switching intermediate suppliers for 20% lower price? Six hidden costs including bridging studies, regulatory filings, and method revalidation can reach $600K.
This guide decodes the seven validation parameters defined in ICH Q2(R2) from an intermediate buyer’s perspective, explains why stability-indicating methods matter for retest dating, and provides six questions buyers should ask suppliers about their analytical methods.
Learn how ICH Q11 starting material rules affect pharmaceutical intermediate sourcing—supplier boundaries, COA red flags, and a practical buyer’s checklist.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.
